Product image of Minocycline Eg (Minocycline) supplied by GNH India

Minocycline Eg

Active Ingredient:
Minocycline
Origin:
EU

Minocycline Eg (Minocycline)

Minocycline, the active ingredient in Minocycline Eg, is a tetracycline antibiotic presented as an oral dosage form for oral use. It treats bacterial infections such as acne, respiratory tract infections, skin and soft‑tissue infections, and chlamydia in adolescents and adults.

GNH India supplies Minocycline Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Eurogenerics N.V./S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Minocycline is a broad‑spectrum tetracycline antibiotic used to manage bacterial infections affecting the skin, respiratory system and genitourinary tract.

  • Acne vulgaris: reduces inflammatory lesions and bacterial colonisation of the skin.
  • Respiratory tract infections: treats community‑acquired pneumonia and bronchitis caused by susceptible organisms.
  • Skin and soft‑tissue infections: combats cellulitis, abscesses and infected wounds.
  • Chlamydia infections: eradicates Chlamydia trachomatis in genital and ocular disease.

How It Works

  • Minocycline inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, blocking the addition of aminoacyl‑tRNA to the growing peptide chain. This action prevents bacterial growth and replication, rendering the organism unable to sustain infection. The drug is bacteriostatic against most susceptible Gram‑positive and Gram‑negative bacteria.

Side Effects

Minocycline may cause a range of adverse reactions, from mild to severe. Awareness of common and serious events helps clinicians monitor therapy.

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Diarrhoea: loose stools, often transient.
  • Dizziness: sensation of light‑headedness.
  • Photosensitivity: increased skin reaction to sunlight.
  • Hyperpigmentation: skin or nail discoloration.
  • Vestibular disturbances: vertigo or balance issues.

Serious or Rare Side Effects

  • Hepatotoxicity: elevated liver enzymes or jaundice.
  • Severe hypersensitivity: rash, Stevens‑Johnson syndrome, or anaphylaxis.
  • Autoimmune reactions: drug‑induced lupus‑like syndrome.
  • Pseudotumor cerebri: increased intracranial pressure causing headache and visual changes.
  • Hematologic effects: agranulocytosis or thrombocytopenia.
  • Renal impairment: interstitial nephritis or worsening kidney function.

Precautions & Warnings

Before prescribing Minocycline, clinicians should consider several safety measures.

  • Pregnancy: Category D – avoid use unless benefits outweigh risks.
  • Breastfeeding: contraindicated; drug passes into milk.
  • Liver disease: monitor hepatic function; dose adjustment may be needed.
  • Renal impairment: assess kidney function; consider dose reduction.
  • Drug‑induced lupus: discontinue if systemic symptoms develop.
  • Store at ambient temperature: keep below 25 °C, in original container, protected from moisture and light.

Avoid Interactions

Minocycline can alter the activity of several concomitant medicines; interactions are grouped by clinical significance.

Major Interactions (Avoid)

  • Antacids containing aluminium or magnesium: reduce absorption of minocycline.
  • Warfarin: may enhance anticoagulant effect, increasing bleeding risk.
  • Oral contraceptives: may decrease efficacy, leading to unintended pregnancy.

Moderate Interactions (Monitor Closely)

  • Cyclosporine: increased nephrotoxicity risk.
  • Phenytoin: may reduce minocycline levels.
  • Vitamin D supplements: may exacerbate hypercalcemia.
  • Rifampin: may lower minocycline concentrations.
  • Digoxin: potential for altered serum levels.

Frequently Asked Questions

Minocycline Eg is prescribed for bacterial infections such as acne vulgaris, respiratory tract infections like pneumonia and bronchitis, skin and soft‑tissue infections including cellulitis and abscesses, and chlamydia infections of the genital or ocular tract. It targets susceptible Gram‑positive and Gram‑negative organisms.

Minocycline binds to the 30S subunit of bacterial ribosomes, blocking the addition of aminoacyl‑tRNA to the growing peptide chain. This inhibits protein synthesis, halting bacterial growth and allowing the immune system to clear the infection. The action is bacteriostatic for most susceptible strains.

The dosage of Minocycline Eg is determined by the prescribing clinician based on the specific infection, patient age, weight, renal and hepatic function, and other clinical factors. Only a qualified health professional should set the dose and duration of therapy.

Minocycline is classified as Pregnancy Category D, indicating evidence of risk to the fetus; it should be avoided unless the potential benefit justifies the risk. It is also contraindicated during breastfeeding because it can be excreted in milk and may affect the infant.

To request Minocycline Eg, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Minocycline offers a broader spectrum against certain resistant organisms and has better tissue penetration than doxycycline, but it may cause more vestibular side effects. Choice of agent depends on infection type, susceptibility patterns, patient tolerance, and specific safety considerations.

Minocycline Eg should be stored at ambient temperature, below 25 °C, in its original packaging to protect from moisture and light. Keep the product out of reach of children and avoid storing in humid or excessively hot environments.

Minocycline Eg is taken orally, usually with a full glass of water. It can be taken with or without food, but avoiding simultaneous intake of antacids containing aluminium or magnesium helps maintain optimal absorption.

Serious risks include hepatotoxicity, severe hypersensitivity reactions such as Stevens‑Johnson syndrome, drug‑induced lupus‑like syndrome, pseudotumor cerebri (increased intracranial pressure), and hematologic abnormalities like agranulocytosis. Patients should be monitored for signs of these conditions and seek immediate medical attention if they occur.

Minocycline Eg should not be used by pregnant women unless absolutely necessary, breastfeeding mothers, patients with known hypersensitivity to tetracyclines, those with severe hepatic or renal impairment without dose adjustment, and individuals with a history of drug‑induced lupus or pseudotumor cerebri.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Minocycline

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT